Review
miRNAs in Melanoma: Diagnostic, prognostic, and therapeutic strategies
- Department of Medical Biology, Faculty of Medicine, Van Yuzuncu Yil University, Van, Turkey
- Department of Medical Biology and Genetics, Faculty of Medicine, İnönü University, Malatya, Turkey
- Department of Medical Biology, Faculty of Medicine, Cukurova University, Adana, Turkey
Correspondence to:
Gulsah Evyapan,
Department of Medical Biology, Faculty of Medicine, Van Yuzuncu Yil University, Van, Turkey.
ORCID:
https://orcid.org/0000-0001-9870-4783.
Email:
gulsahevyapan.ge@gmail.com.
Published:
2024-11-30
Abstract
Melanoma is a highly aggressive and deadly form of skin cancer, with its incidence and mortality rates increasing significantly worldwide. Recent research suggests that miRNA-based therapies could help improve outcomes for melanoma patients by controlling gene expression at the posttranscriptional level, which affects how the tumor grows and spreads. This review aims to examine the role of microRNAs (miRNAs) in melanoma progression, highlighting their potential as therapeutic targets and exploring how they may be utilized in diagnostic and prognostic processes.